NKILA is a Novel Suppressor of Local Recurrence in Women Breast Malignant Phyllodes Tumor Patients Via Inhibition of the NF-κB Pathway

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Jul 19

PMID 39027510

Authors

Ying Mi

Le Yan

Haiyun Jin

Ming Jin

Di Zhu

Hongyan Huang

Kai Han

Jibo Huang

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to explore the functional mechanism of NF-Kappa B-interacting Long non-protein coding RNA (NKILA) in breast malignant phyllodes tumors (BMPTs). The expression and functional role of NKILA were investigated by performing qRT‒PCR, Transwell assays, and CCK‒8 assays in primary BMPT cells. A Kaplan‒Meier curve was used to assess overall survival (OS) and local recurrence-free survival (LRFS). The location and expression levels of NKILA and P65 were determined by fluorescence in situ hybridization (FISH) and immunofluorescence (IF), respectively. NKILA was downregulated in patients with BMPT, especially in patients with local recurrence. NKILA had an antitumor effect and promoted the chemosensitivity of cells to cisplatin by blocking P65 phosphorylation and nuclear translocation. In conclusion, NKILA may be a potential therapeutic target for BMPT, especially for BMPT patients with local recurrence.

References

Gao Z, Xu J, Fan Y, Qi Y, Wang S, Zhao S . PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. J Exp Clin Cancer Res. 2022; 41(1):223. PMC: 9284800. DOI: 10.1186/s13046-022-02431-0. View

Hu D, Zhong T, Dai Q . Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway. Technol Cancer Res Treat. 2020; 19:1533033820960747. PMC: 7645807. DOI: 10.1177/1533033820960747. View

Zhou Z, Wang C, Sun X, Yang Z, Chen X, Shao Z . Prognostic factors in breast phyllodes tumors: a nomogram based on a retrospective cohort study of 404 patients. Cancer Med. 2018; 7(4):1030-1042. PMC: 5911599. DOI: 10.1002/cam4.1327. View

Rosenberger L, Thomas S, Nimbkar S, Hieken T, Ludwig K, Jacobs L . Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines. J Clin Oncol. 2020; 39(3):178-189. PMC: 8462612. DOI: 10.1200/JCO.20.02647. View

Choi D, Chi H, Lee S, Kwon Y, Park S, Sim S . A Rare Case of Phyllodes Tumor Metastasis to the Stomach Presenting as Anemia. Cancer Res Treat. 2016; 49(3):846-849. PMC: 5512377. DOI: 10.4143/crt.2016.188. View

Choi N, Kim K, Shin K, Kim Y, Moon H, Park W . Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08). Breast Cancer Res Treat. 2018; 171(2):335-344. DOI: 10.1007/s10549-018-4838-3. View

Shan J, Zhang S, Wang Z, Fu Y, Li L, Wang X . Breast malignant phyllodes tumor with rare pelvic metastases and long-term overall survival: A case report and literature review. Medicine (Baltimore). 2016; 95(38):e4942. PMC: 5044921. DOI: 10.1097/MD.0000000000004942. View

Chen Z, Li S, Shen L, Wei X, Zhu H, Wang X . NF-kappa B interacting long noncoding RNA enhances the Warburg effect and angiogenesis and is associated with decreased survival of patients with gliomas. Cell Death Dis. 2020; 11(5):323. PMC: 7206073. DOI: 10.1038/s41419-020-2520-2. View

Strode M, Khoury T, Mangieri C, Takabe K . Update on the diagnosis and management of malignant phyllodes tumors of the breast. Breast. 2017; 33:91-96. DOI: 10.1016/j.breast.2017.03.001. View

10.

Liu T, Han C, Fang P, Ma Z, Wang X, Chen H . Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma. J Hematol Oncol. 2022; 15(1):141. PMC: 9548164. DOI: 10.1186/s13045-022-01359-4. View

11.

Gupta S, Awasthee N, Rai V, Chava S, Gunda V, Challagundla K . Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases. Biochim Biophys Acta Rev Cancer. 2019; 1873(1):188316. PMC: 7775411. DOI: 10.1016/j.bbcan.2019.188316. View

12.

Chen S, Li X, Zhang J, Li L, Wang X, Zhu Y . Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer. J Gastrointest Oncol. 2021; 12(5):2157-2171. PMC: 8576217. DOI: 10.21037/jgo-21-494. View

13.

Chang E, Peled A, Foster R, Lin C, Zeidler K, Ewing C . Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg. 2012; 255(6):1151-7. DOI: 10.1097/SLA.0b013e31824f9769. View

14.

Wei J, Tan Y, Cai Y, Yuan Z, Yang D, Wang S . Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chin J Cancer. 2014; 33(10):492-500. PMC: 4198752. DOI: 10.5732/cjc.014.10048. View

15.

Liu F, Tian T, Zhang Z, Xie S, Yang J, Zhu L . Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma. Nat Metab. 2022; 4(8):1022-1040. DOI: 10.1038/s42255-022-00616-7. View

16.

Mas A, Huarte M . Long Noncoding RNA Signatures as Cancer Biomarkers. J Clin Oncol. 2023; 41(16):3059-3062. DOI: 10.1200/JCO.23.00381. View

17.

Huang D, Chen J, Yang L, Ouyang Q, Li J, Lao L . NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death. Nat Immunol. 2018; 19(10):1112-1125. DOI: 10.1038/s41590-018-0207-y. View

18.

Van Osdol A, Landercasper J, Andersen J, Ellis R, Gensch E, Johnson J . Determining whether excision of all fibroepithelial lesions of the breast is needed to exclude phyllodes tumor: upgrade rate of fibroepithelial lesions of the breast to phyllodes tumor. JAMA Surg. 2014; 149(10):1081-5. DOI: 10.1001/jamasurg.2014.73. View

19.

Nie Y, Huang H, Guo M, Chen J, Wu W, Li W . Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy. Clin Cancer Res. 2019; 25(13):3873-3886. DOI: 10.1158/1078-0432.CCR-18-3421. View

20.

Hashemi M, Zaferani Arani H, Orouei S, Fallah S, Ghorbani A, Khaledabadi M . EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomed Pharmacother. 2022; 155:113774. DOI: 10.1016/j.biopha.2022.113774. View